These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28321074)

  • 1. Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.
    Mashima K; Yano S; Yokoyama H; Saito T; Machishima T; Shimada T; Yahagi Y; Takahara S; Sugiyama K; Ogasawara Y; Minami J; Kamiyama Y; Katsube A; Suzuki K; Ohshima S; Yamada H; Usui N; Aiba K
    Intern Med; 2017; 56(6):701-706. PubMed ID: 28321074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.
    Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia].
    Nagata H; Fujino T; Muramatsu A; Kawaji Y; Kuriyama K; Oshiro M; Hirakawa Y; Iwai T; Uchiyama H
    Rinsho Ketsueki; 2018; 59(4):407-413. PubMed ID: 29743400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly progressive Epstein-Barr virus-associated lymphoproliferative disorder unpredictable by weekly viral load monitoring.
    Wakabayashi S; Ohashi K; Hanajiri R; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
    Intern Med; 2010; 49(10):931-5. PubMed ID: 20467179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia.
    Shimizu H; Kobayashi N; Mihara M; Iriuchishima H; Ishizaki T; Kojima Y; Handa H
    Acta Haematol; 2016; 136(3):174-7. PubMed ID: 27561697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia.
    Calistri E; Tiribelli M; Battista M; Michelutti A; Corbellino M; Viale P; Fanin R; Damiani D
    Am J Hematol; 2006 May; 81(5):355-7. PubMed ID: 16628717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Epstein-Barr virus-associated leukemic lymphoma in a patient treated with rabbit antithymocyte globulin and cyclosporine for hepatitis-associated aplastic anemia.
    Ohata K; Iwaki N; Kotani T; Kondo Y; Yamazaki H; Nakao S
    Acta Haematol; 2012; 127(2):96-9. PubMed ID: 22178718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
    Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H
    Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy.
    Viola GM; Zu Y; Baker KR; Aslam S
    Med Oncol; 2011 Dec; 28(4):1604-8. PubMed ID: 20680523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy.
    Kawarada Y; Hara R; Kitahara T; Numata H; Watanabe S; Yamada M; Ando K
    Intern Med; 2023 Sep; 62(17):2553-2557. PubMed ID: 36725050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
    Nash RA; Dansey R; Storek J; Georges GE; Bowen JD; Holmberg LA; Kraft GH; Mayes MD; McDonagh KT; Chen CS; Dipersio J; Lemaistre CF; Pavletic S; Sullivan KM; Sunderhaus J; Furst DE; McSweeney PA
    Biol Blood Marrow Transplant; 2003 Sep; 9(9):583-91. PubMed ID: 14506660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.
    Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW
    Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
    Kuriyama T; Kawano N; Yamashita K; Ueda A
    J Clin Exp Hematop; 2014; 54(2):149-53. PubMed ID: 25318948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-induced polyclonal lymphoproliferative disorder of lymphoplasmacytic type in an autopsy case of aplastic anemia treated twice with anti-thymocyte globulin therapy.
    Okada E; Shigeyasu H; Inaguma Y; Emi N; Sano K; Tsutsumi Y
    Pathol Int; 2015 May; 65(5):274-6. PubMed ID: 25677466
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation.
    Hoshino Y; Kimura H; Tanaka N; Tsuge I; Kudo K; Horibe K; Kato K; Matsuyama T; Kikuta A; Kojima S; Morishima T
    Br J Haematol; 2001 Oct; 115(1):105-11. PubMed ID: 11722419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple Sclerosis.
    Mehra V; Rhone E; Widya S; Zuckerman M; Potter V; Raj K; Kulasekararaj A; McLornan D; de Lavallade H; Benson-Quarm N; Lim C; Ware S; Sudhanva M; Malik O; Nicholas R; Muraro PA; Marsh J; Mufti GJ; Silber E; Pagliuca A; Kazmi MA
    Clin Infect Dis; 2019 Oct; 69(10):1757-1763. PubMed ID: 30980715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia.
    Dorr V; Doolittle G; Woodroof J
    Am J Hematol; 1996 Jun; 52(2):108-13. PubMed ID: 8638630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens.
    Peres E; Savasan S; Klein J; Abidi M; Dansey R; Abella E
    J Clin Microbiol; 2005 Jul; 43(7):3540-3. PubMed ID: 16000501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia after Treatment of Lymphoproliferative Disorder Caused by Rabbit Antithymocyte Globulin.
    Tsukamoto S; Nagao Y; Yamazaki A; Sugita Y; Muto T; Sakai S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Sakaida E; Yokote K; Iseki T; Nakaseko C
    Intern Med; 2015; 54(24):3197-200. PubMed ID: 26666612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.
    Brunstein CG; Weisdorf DJ; DeFor T; Barker JN; Tolar J; van Burik JA; Wagner JE
    Blood; 2006 Oct; 108(8):2874-80. PubMed ID: 16804113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.